Postprandial Effects of Walnut Components Versus Whole Walnuts on Cardiovascular Disease (CVD) Risk Reduction
Postprandial Effects of Walnut Components vs Whole Walnuts on Oxidative Stress, Inflammation, Platelet Function, and Endothelial Function in Volunteers With Moderate Hypercholesterolemia
Sponsor: California Walnut Commission
This NA trial investigates Cardiovascular Disease and is currently completed. California Walnut Commission leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Sep 2023 [monthly]
Completed NA
-
Nov 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Aug 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- California Walnut Commission
- Penn State University
For direct contact, visit the study record on ClinicalTrials.gov .